Trial Profile

Influence of an acidic beverage on the absorption of erlotinib

Status: Completed

Phase of Trial: Phase IV

Latest Information Update: 10 May 2016

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Erlotinib (Primary) ; Omeprazole
Indications Lung cancer
Focus Pharmacokinetics
Acronyms COLA

Most Recent Events

08 Feb 2016 Results published in the Journal of Clinical Oncology
24 Dec 2015 Status changed from recruiting to completed as per Netherlands Trial Register record.
26 Jun 2015 Planned number of patients changed from 36 to 28 as per Netherlands Trial Register record.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com